Myths and facts in neuromuscular pharmacology - New developments in reversing neuromuscular blockade

Minerva Anestesiologica

Volumn 78, Issue 4, 2012, Pages 473-482

  Fink, H ^a   Hollmann, M W ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acetylcholinesterase; Neuromuscular blockade; Pharmacology

Indexed keywords

ACETYLCHOLINESTERASE; ATRACURIUM; ATROPINE; CHOLINESTERASE INHIBITOR; CISATRACURIUM; GLYCOPYRRONIUM BROMIDE; MUSCLE RELAXANT AGENT; PANCURONIUM; ROCURONIUM; SUGAMMADEX; VECURONIUM;

ABSENCE OF SIDE EFFECTS; ALLERGIC REACTION; ANESTHESIA COMPLICATION; BRADYCARDIA; BRONCHOSPASM; CONFUSION; CONSTIPATION; DRUG COST; ENDOTRACHEAL INTUBATION; HUMAN; HYPERSALIVATION; HYPERSENSITIVITY; HYPOTENSION; INCIDENCE; INTESTINE MOTILITY; MORBIDITY; MORTALITY; NAUSEA; NEUROMONITORING; NEUROMUSCULAR BLOCKING; PARALYSIS; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE RESIDUAL CURARIZATION; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; TACHYCARDIA; XEROSTOMIA;

CHOLINESTERASE INHIBITORS; GAMMA-CYCLODEXTRINS; HUMANS; INTUBATION, INTRATRACHEAL; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE COMPLICATIONS;

EID: 84859414160     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Trabold F, Casetta M, Duranteau J, Albaladejo P, Mazoit JX, Samii K et al. Propofol and remifentanil for intubation without muscle relaxant: the effect of the order of injection. Acta Anaesthesiol Scand 2004;48:35-9.
2. Joo HS, Perks WJ, Belo SE. Sevoflurane with remifentanil allows rapid tracheal intubation without neuromuscular blocking agents. Can J Anaesth 2001;48:646-50.
3. Gupta A, Kaur R, Malhotra R, Kale S. Comparative evaluation of different doses of propofol preceded by fentanyl on intubating conditions and pressor response during tracheal intubation without muscle relaxants. Paediatr Anaesth 2006;16:399-405.
4. Nauheimer D, Fink H, Fuchs-Buder T, Geldner G, Hof-mockel R, Ulm K et al. Muscle relaxant use for tracheal intubation in pediatric anaesthesia: a survey of clinical practice in Germany. Paediatr Anaesth Published Online; Oct 13, 2008.
5. Simon L, Boucebci KJ, Orliaguet G, Aubineau JV, Devys JM, Dubousset AM. A survey of practice of tracheal intubation without muscle relaxant in paediatric patients. Paediatr Anaesth 2002;12:36-42.
6. Combes X, Andriamifidy L, Dufresne E, Suen P, Sauvat S, Scherrer E et al. Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort. Br J Anaesth 2007;99:276-81.
7. Schlaich N, Mertzlufft F, Soltesz S, Fuchs-Buder T. Remifentanil and propofol without muscle relaxants or with different doses of rocuronium for tracheal intubation in outpatient anaesthesia. Acta Anaesthesiol Scand 2000;44:720-6.
8. Lieutaud T, Billard V, Khalaf H, Debaene B. Muscle relaxation and increasing doses of propofol improve intubating conditions. Can J Anaesth 2003;50:121-6.
9. Mencke T, Echternach M, Kleinschmidt S, Lux P, Barth V, Plinkert PK, Fuchs-Buder T. Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology 2003;98:1049-56.
10. Domino KB, Posner KL, Caplan RA, Cheney FW. Airway injury during anesthesia: a closed claims analysis. Anesthesiology 1999;91:1703-11.
11. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010;112:1013-22.
12. Schreiber JU, Mucha E, Fuchs-Buder T. Residual paralysis following a single dose of atracurium: results from a quality assurance trial. Eur J Anaesthesiol 2010;27:993-4.
13. Murphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol 2006;72:97-109.
14. Maybauer DM, Geldner G, Blobner M, Puhringer F, Hof M.R, Rex C et al. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia 2007;62: 12-7.
15. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997;41:1095-103.
16. Fink H, Geldner G, Fuchs-Buder T, Hofmockel R, Ulm K, Wallek B et al. [Muscle relaxants in Germany 2005: A comparison of application customs in hospitals and private practices.]. Anaesthesist 2006;55:668-78.
17. Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997;87:1035-43.
18. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000;92:977-84.
19. Eriksson LI. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Scand 1996;40:520-3.
20. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005;102:257-68; quiz 491-252.
21. Viby Mogensen J, Chraemer Jorgensen B, Ording H. Residual curarization in the recovery room. Anesthesiology 1979;50:539-41.
22. Baillard C, Clec'h C, Catineau J, Salhi F, Gehan G, Cupa M et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 2005;95:622-6.
23. Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M. Einsatz des neuromuskularen Monitorings in Deutschland. Anaesthesist 2003;52:522-6.
24. Fruergaard K, Viby-Mogensen J, Berg H, el-Mahdy AM. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Acta Anaesthesiol Scand 1998;42:1168-74.
25. Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jorgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985;63:440-3.
26. Drenck NE, Ueda N, Olsen NV, Engboek J, Jensen E, Skovgaard LT et al. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of- four. Anesthesiology 1989;70:578-81.
27. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology 2003;98:1037-9.
28. Gottlieb JD, Sweet RB. The antagonism of curare: the cardiac effects of atropine and neostigmine. Can Anaesth Soc J 1963;10:114-21.
29. Long G, Marsh HM. The effect on heart rate of neuromuscular blockade reversal by pyridostigmine. Anaesth Intensive Care 1981;9:144-6.
30. Arsura EL, Brunner NG, Namba T, Grob D. Adverse cardiovascular effects of anticholinesterase medications. Am J Med Sci 1987;293:18-23.
31. Pratt CI. Bronchospasm after neostigmine. Anaesthesia 1988;43:248.
32. Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth 2009;103:115-29.
33. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999;341:137-41.
34. Law NM, Bharucha AE, Undale AS, Zinsmeister AR. Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans. Am J Physiol Gastrointest Liver Physiol 2001;281:G1228-37.
35. Bartkowski RR. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium. Anesthesia and Analgesia 1987;66:594-8.
36. Kopman A, Kopman D, Ng J, Zank L. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function. J Clin Anesth 2005;17:30-5.
37. Lien CA, Belmont MR, Wray Roth DL, Okamoto M, Abalos A, Savarese JJ. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery. Anesthesiology 1999;91:119-26.
38. Kurkov SV, Messner M, Lucassen M, van den Dobbelsteen DJ, den Engelsman J, Loftsson T. Evaluation of sugammadex self-association. Int J Pharm 2011;413:134-9.
39. Peeters P, Passier P, Smeets J, Zwiers A, de Zwart M, van de Wetering-Krebbers S et al. Sugammadex is cleared rapidly and primarily unchanged via renal excretion. Biopharm Drug Dispos 2011;32:159-67.
40. Puhringer FK, Rex C, Sielenkamper AW, Claudius C, Larsen PB, Prins ME et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008;109:188-97.
41. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008;109:816-24.
42. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007;106:283-88.
43. Shields M, Giovannelli M, Mirakhur R, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006;96:36-43.
44. Schaller SJ, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology 2010;113:1054-60.
45. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia 2011;66:217-9.
46. Clinical trials.gov. Sugammadex Hypersensitivity Study (Study P06042) (COMPLETED) [Internet]. [cited 2012 February 21]. Available at: http://clinicaltrials.gov/ct2/ show/NCT00988065
47. Cammu G, de Kam PJ, De Graeve K, Van Den Heuvel M, Suy K, Morias K et al. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study. Br J Anaesth 2010;105:487-92.
48. Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008;101:492-7.
49. Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight fordosage of sugammadex in morbidly obese patients. Anaesthesia 2011;66:721-5.
50. Suzuki T, Kitajima O, Ueda K, Kondo Y, Kato J, Ogawa S. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients. Br J Anaesth 2011 [Epub ahead of print].
51. Sharp LM, Levy DM. Rapid sequence induction in obstetrics revisited. Curr Opin Anaesthesiol 2009;22:357-61.
52. Puhringer FK, Kristen P, Rex C. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases. Br J Anaesth 2010;105:657-60.
53. Williamson RM, Mallaiah S, Barclay P. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia. Acta Anaesthesiol Scand 2011 [Epub ahead of print].
54. US Food and Drug Administration. Sugammadex, NDA 22-225, Anesthetic and Life Support Drugs Advisory Committee March 11, 2008. Available at: http://wwwfdagov/ohrms/dockets/ac/08/slides/2008-4346s1-01-Schering-Plough-corebackuppdf2008.
55. Zwiers A, van den Heuvel M, Smeets J, Rutherford S. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach. Clin Drug Investig 2011;31:101-11.
56. Chambers D, Paulden M, Paton F, Heirs M, Duffy S, Hunter JM et al. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment. Br J Anaesth 2010;105: 568-75.
57. Paton F, Paulden M, Chambers D, Heirs M, Duffy S, Hunter JM et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth 2010;105:558-67.